Possibilities of modern biomarkers for assessing the risk of developing ventricular tachyarrhythmias and sudden cardiac death in patients with chronic heart failure | Zendy

A. Zh. Gasparyan | Zendy; Н. Б. Шлевков | Zendy; A. A. Skvortsov | Zendy

Open Access

Possibilities of modern biomarkers for assessing the risk of developing ventricular tachyarrhythmias and sudden cardiac death in patients with chronic heart failure

Author(s) -

A. Zh. Gasparyan,

Н. Б. Шлевков,

A. A. Skvortsov

Publication year - 2020

Publication title -

kardiologiia

Language(s) - English

Resource type - Journals

eISSN - 2412-5660

pISSN - 0022-9040

DOI - 10.18087/cardio.2020.4.n487

Subject(s) - medicine , heart failure , cardiology , sudden cardiac death , pathological , galectin 3 , sudden death , natriuretic peptide

Current biomarkers allow diagnosing a wide array of pathological processes and evaluating effects of therapies and prognosis for cardiological patients. This review focuses on a possibility of using N-terminal pro-brain natriuretic peptide (NT-proBNP), soluble suppressor of tumorigenicity 2 (sST2), galectin-3, and other biomarkers in patients with chronic heart failure for evaluating the risk of life-threatening ventricular tachyarrhythmias and sudden cardiac death.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research